Jong-min Kim acquired 0.93% stake in Myungmoon Pharm. Co., LTD. from Woo, Seok-Min for approximately KRW 300 million.
January 09, 2014
Share
Jong-min Kim acquired 0.93% stake in Myungmoon Pharm. Co., LTD. (KOSE:A017180) from Woo, Seok-Min for approximately KRW 300 million on January 9, 2014. Woo, Seok-Min sold 0.16 million shares of Myungmoon Pharm for KRW 1900 per share, and holds 4.54 million shares after the transaction.
Jong-min Kim completed the acquisition of 0.93% stake in Myungmoon Pharm. Co., LTD. (KOSE:A017180) from Woo, Seok-Min on January 9, 2014.
MyungMoon Pharm. Co., Ltd. is a Korea-based company mainly engaged in the manufacture of pharmaceuticals. Its products include ethical (ETC) drugs and over the counter (OTC) drugs. Its ETC drugs include anesthetic agents, digestive system drugs, rheumatoid arthritis remedies, central nervous system drugs, circulatory drugs, anti-depressant agents, anti-diabetic agents, antibiotics, hormone agents, narcotics and drugs for dermatology systems. Its OTC drugs include antinauseant agents, hepatic agents, immunologic agents, antidiarrheal agents, skin external preparations, antiallergic agents, muscle relaxants, cold drugs and parasiticides. The Company is also involved in the operation golf courses. January 2, 2012, the Company completed the merger with its wholly owned subsidiary.
MYUNGMOON PHARM CO.,LTD 
